Benzodiazepine, Z-drug, and sleep medication prescriptions in male and female people with opioid use disorder on buprenorphine and comorbid insomnia: an analysis of multistate insurance claims
SLEEP · 13.06.2023 · 46 (6)
DOI: 10.1093/sleep/zsad083 ↗Kurz gefasst
Fachartikel in der Zeitschrift SLEEP, online erschienen am 27.03.2023. Verfasst von Caitlin E Martin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology and VCU Institute for Drug and Alcohol Studies, Virginia Commonwealth University School of Medicine, Richmond…. Hauptthemen laut MEDLINE: Buprenorphine, Sleep Initiation and Maintenance Disorders, Opioid-Related Disorders, Insurance. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, NCATS NIH HHS, NIMH NIH HHS.
Themen: Sucht und Abhängigkeit, Schlaf
Abstract (Originalsprache)
Study Objectives In adult populations, women are more likely than men to be prescribed benzodiazepines. However, such disparities have not been investigated in people with opioid use disorder (OUD) and insomnia receiving buprenorphine, a population with particularly high sedative/hypnotic receipt. This retrospective cohort study used administrative claims data from Merative MarketScan Commercial and MultiState Medicaid Databases (2006–2016) to investigate sex differences in the receipt of insomnia medication prescriptions among patients in OUD treatment with buprenorphine.
Methods
We included people aged 12–64 years with diagnoses of insomnia and OUD-initiating buprenorphine during the study timeframe. The predictor variable was sex (female versus male). The primary outcome was receipt of insomnia medication prescription within 60 days of buprenorphine start, encompassing benzodiazepines, Z-drugs, or non-sedative/hypnotic insomnia medications (e.g. hydroxyzine, trazodone, and mirtazapine). Associations between sex and benzodiazepine, Z-drug, and other insomnia medication prescription receipt were estimated using Poisson regression models.
Results
Our sample included 9510 individuals (female n = 4637; male n = 4873) initiating buprenorphine for OUD who also had insomnia, of whom 6569 (69.1%) received benzodiazepines, 3891 (40.9%) Z-drugs, and 8441 (88.8%) non-sedative/hypnotic medications. Poisson regression models, adjusting for sex differences in psychiatric comorbidities, found female sex to be associated with a slightly increased likelihood of prescription receipt: benzodiazepines (risk ratio [RR], RR = 1.17 [1.11–1.23]), Z-drugs (RR = 1.26 [1.18–1.34]), and non-sedative/hypnotic insomnia medication (RR = 1.07, [1.02–1.12]).
Conclusions
Sleep medications are commonly being prescribed to individuals with insomnia in OUD treatment with buprenorphine, with sex-based disparities indicating a higher prescribing impact among female than male OUD treatment patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology and VCU Institute for Drug and Alcohol Studies, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.
- Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
- National Sleep Foundation, Washington DC, USA.
- Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA.
- Alvin J Siteman Cancer Center, Barnes Jewish Hospital, St. Louis, MO, USA.
- Departments of Family and Community Medicine and Health and Outcomes Research, St. Louis University, St. Louis, MO, USA.
ORCID-Profile: Caitlin E Martin, Joseph M Dzierewski, Kevin Y Xu
Förderung
- NIDA NIH HHS
- NCATS NIH HHS
- NIMH NIH HHS
- St. Louis University Research Institute
- Washington University Institute of Clinical
- National Center for Advancing Translational Sciences
Zitieren
APA
Martin, C. E., Patel, H., Dzierewski, J. M., Moeller, F. G., Bierut, L. J., Grucza, R. A., & Xu, K. Y. (2023). Benzodiazepine, Z-drug, and sleep medication prescriptions in male and female people with opioid use disorder on buprenorphine and comorbid insomnia: an analysis of multistate insurance claims. SLEEP, 46(6). https://doi.org/10.1093/sleep/zsad083
Vancouver
Martin CE, Patel H, Dzierewski JM, Moeller FG, Bierut LJ, Grucza RA, et al. Benzodiazepine, Z-drug, and sleep medication prescriptions in male and female people with opioid use disorder on buprenorphine and comorbid insomnia: an analysis of multistate insurance claims. SLEEP. 2023;46(6). doi:10.1093/sleep/zsad083
BibTeX
@article{Martin2023,
author = {Martin, Caitlin E and Patel, Hetal and Dzierewski, Joseph M and Moeller, F Gerard and Bierut, Laura J and Grucza, Richard A and Xu, Kevin Y},
title = {Benzodiazepine, Z-drug, and sleep medication prescriptions in male and female people with opioid use disorder on buprenorphine and comorbid insomnia: an analysis of multistate insurance claims},
journal = {SLEEP},
year = {2023},
volume = {46},
number = {6},
doi = {10.1093/sleep/zsad083}
}
EUVIMED